Millennium Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Millennium Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,549	Closed	-$178K	–	7872
2022 Q1	$178K	Buy	+19,549	New	+$297K	﹤0.01%	5875
2021 Q4	–	Sell	-19,384	Closed	-$634K	–	7706
2021 Q3	$634K	Sell	19,384 -48,061	-71%	-$1.76M	﹤0.01%	5125
2021 Q2	$2.81M	Buy	67,445 +47,585	+240%	+$2.44M	﹤0.01%	3522
2021 Q1	$1.3M	Buy	19,860 +16,060	+423%	+$1.12M	﹤0.01%	3957
2020 Q4	$250K	Sell	3,800 -1,545	-29%	-$101K	﹤0.01%	4680
2020 Q3	$290	Sell	5,345 -11,906	-69%	-$911K	﹤0.01%	3864
2020 Q2	$1.65M	Buy	17,251 +16,605	+2,570%	+$1.24M	﹤0.01%	2660
2020 Q1	$33K	Sell	646 -105	-14%	-$11K	﹤0.01%	3706
2019 Q4	$62K	Sell	751 -3,032	-80%	-$213K	﹤0.01%	4077
2019 Q3	$323K	Buy	+3,783	New	+$404K	﹤0.01%	3526
2019 Q2	–	Sell	-1,879	Closed	-$339K	–	4644
2019 Q1	$339K	Sell	1,879 -1,211	-39%	-$175K	﹤0.01%	3481
2018 Q4	$343K	Sell	3,090 -3,265	-51%	-$425K	﹤0.01%	3160
2018 Q3	$858K	Sell	6,355 -2,177	-26%	-$300K	﹤0.01%	2959
2018 Q2	$1.18M	Sell	8,532 -8,962	-51%	-$1.23M	﹤0.01%	2736
2018 Q1	$2.41M	Sell	17,494 -2,228	-11%	-$303K	﹤0.01%	2203
2017 Q4	$2.43M	Buy	19,722 +9,951	+102%	+$1.37M	﹤0.01%	2167
2017 Q3	$1.33M	Buy	9,771 +1,212	+14%	+$183K	﹤0.01%	2375
2017 Q2	$1.5M	Buy	8,559 +7,522	+725%	+$1.07M	﹤0.01%	2239
2017 Q1	$124K	Sell	1,037 -456	-31%	-$47.5K	﹤0.01%	3301
2016 Q4	$146K	Sell	1,493 -3,389	-69%	-$311K	﹤0.01%	3146
2016 Q3	$458K	Sell	4,882 -12,445	-72%	-$1.25M	﹤0.01%	2639
2016 Q2	$1.87M	Sell	17,327 -15,276	-47%	-$1.79M	﹤0.01%	1823
2016 Q1	$3.91M	Buy	32,603 +13,468	+70%	+$1.41M	0.01%	1390
2015 Q4	$2.28M	Buy	19,135 +3,216	+20%	+$415K	﹤0.01%	1835
2015 Q3	$2.71M	Sell	15,919 -14,077	-47%	-$2.7M	0.01%	1713
2015 Q2	$5.81M	Buy	29,996 +7,968	+36%	+$1.48M	0.01%	1302
2015 Q1	$3.27M	Buy	22,028 +16,412	+292%	+$2.5M	0.01%	1655
2014 Q4	$876K	Buy	5,616 +3,641	+184%	+$524K	﹤0.01%	2579
2014 Q3	$283K	Sell	1,975 -1,907	-49%	-$276K	﹤0.01%	3129
2014 Q2	$507K	Sell	3,882 -42,808	-92%	-$5.44M	﹤0.01%	2584
2014 Q1	$5.71M	Buy	46,690 +21,496	+85%	+$2.33M	0.02%	1139
2013 Q4	$2.68M	Buy	25,194 +6,627	+36%	+$643K	0.01%	1607
2013 Q3	$2.08M	Buy	18,567 +2,504	+16%	+$284K	0.01%	1658
2013 Q2	$1.81M	Buy	+16,063	New	+$1.96M	0.01%	1643

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's SRGA Position: Q2 2022 in Review

Millennium Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 19,549 shares — an estimated $178K sold.

Millennium Management first reported a position in SRGA in Q2 2013 and held it in 34 quarters. The position peaked at $5.81M in Q2 2015. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

Millennium Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 19,549 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $178K.
Millennium Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 34 quarters.
Millennium Management's Surgalign Holdings, Inc. Common Stock position peaked at $5.81M in Q2 2015.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.